<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03918694</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00143319</org_study_id>
    <nct_id>NCT03918694</nct_id>
  </id_info>
  <brief_title>Vitamin C Supplement for Lumbar Spine Surgery</brief_title>
  <official_title>Vitamin C Supplementation for Lumbar Spine Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Kansas Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kansas Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      By doing this study, researchers hope to learn effects of Vit C on lumbar spine surgery
      outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lumbar spine surgeries are common procedures for management of low back pain and their
      prevalence is increasing. However, their outcomes are less than optimal.

      An effective and inexpensive solution to minimizing surgical complications and expediting
      recovery following lumbar spine surgery could be supplementation using high doses of vitamin
      C, also known as ascorbic acid. Vit C can help reduce oxidative stress and inflammation and
      improve immune system and body's own chemicals to fight pain.

      The researchers want to examine if Vit C is effective in decreasing pain and pain medications
      and improving function. Gaining a better understanding of effects of Vit C on patient
      recovery may lead to improved outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 24, 2019</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2 groups: placebo and Vitamin C</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Blinded pilot randomized control trial</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Recruitment feasibility outcome</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>The number of participants recruited and enrolled.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adherence feasibility outcome</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>Calculate adherence in percentage as subjects enrolled versus completed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain intensity: numeric rating pain scale</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>self reported 0-10 numeric rating pain scale where 0=no pain and 10=most pain imagined</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain medication consumption</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>Use of opioids and non-opioids analgesics documented in patients' health records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Function</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>Gait distance in feet will be obtained during physical therapy visit</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Would healing</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>Surgical incision observation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Beck depression inventory</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>A standard questionnaire with 1 - 40 points, 1=no depression and 40=extreme depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vit C level</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>Serum level of Vit C in umol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck anxiety inventory</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>A standard questionnaire with 21 questions. Scores 0-21=low anxiety, scores 22-35=moderate anxiety and scores 36 and above=potentially concerning level of anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2011 Fibromyalgia (FM) survey</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>A standard questionnaire for centralized pain. Scores 3-6 in widespread pain index and 9 or greater in symptom severity suggest widespread pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fatigue questionnaire</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>A standard questionnaire with 10 fatigue related questions. Each measured on 1-5 Likert scale. Higher numbers indicate greater fatigue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburg sleep scale</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>A standard questionnaires to examine sleep problems. A total of 5 scores or greater indicate poor sleep quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain catastrophizing scale</measure>
    <time_frame>up to 7 weeks</time_frame>
    <description>A standard scale to measure catastrophizing thoughts. Higher numbers indicate greater catastrophizing thoughts</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Lumbar Spine Surgery</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive Vit C tablets</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive placebo tablets</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin C</intervention_name>
    <description>Daily use of Vit C tablets</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Daily use of placebo tablets</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled to have a lumbar spine fusion

          -  Can read and understand the English language

          -  BMI 35 or less

        Exclusion Criteria:

          -  Patients taking certain medications

          -  lumbar spine laminectomy or discectomy

          -  taking a Vit C supplement

          -  pregnancy

          -  Cauda equine syndrome or spinal tumor

          -  neurological, neurodegenerative or cognitive issues

          -  renal pathology

          -  sickle cell anemia

          -  iron metabolism disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neena Sharma, PT, PhD, CMPT</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kansas Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neena Sharma, PT, PhD, CMPT</last_name>
    <phone>913 588-4566</phone>
    <phone_ext>4566</phone_ext>
    <email>nsharma@kumc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neena Sharma, PT, PhD, CMPT</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 4, 2019</study_first_submitted>
  <study_first_submitted_qc>April 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2019</study_first_posted>
  <last_update_submitted>January 31, 2020</last_update_submitted>
  <last_update_submitted_qc>January 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

